Detalhe da pesquisa
1.
A tool for evaluating heterogeneity in avidity of polyclonal antibodies.
Front Immunol
; 14: 1049673, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36875126
2.
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions.
bioRxiv
; 2023 Jul 26.
Artigo
Inglês
| MEDLINE | ID: mdl-37546738
3.
Leveraging antigenic seniority for maternal vaccination to prevent mother-to-child transmission of HIV-1.
NPJ Vaccines
; 7(1): 87, 2022 Jul 30.
Artigo
Inglês
| MEDLINE | ID: mdl-35907918
4.
Cold sensitivity of the SARS-CoV-2 spike ectodomain.
Nat Struct Mol Biol
; 28(2): 128-131, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33402708
5.
Disruption of the HIV-1 Envelope allosteric network blocks CD4-induced rearrangements.
Nat Commun
; 11(1): 520, 2020 01 24.
Artigo
Inglês
| MEDLINE | ID: mdl-31980614
6.
Potent and broad HIV-neutralizing antibodies in memory B cells and plasma.
Sci Immunol
; 2(7)2017 Jan 27.
Artigo
Inglês
| MEDLINE | ID: mdl-28783671
7.
Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages.
Sci Transl Med
; 8(336): 336ra62, 2016 04 27.
Artigo
Inglês
| MEDLINE | ID: mdl-27122615
8.
Structural analysis of the unmutated ancestor of the HIV-1 envelope V2 region antibody CH58 isolated from an RV144 vaccine efficacy trial vaccinee.
EBioMedicine
; 2(7): 713-22, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-26288844